Mostra i principali dati dell'item
Miliary tuberculosis in a patient with rheumatoid arthritis following treatment with anti-TNF-α
dc.creator | Papaioannou, A. I. | en |
dc.creator | Kostikas, K. | en |
dc.creator | Gerogianni, E. | en |
dc.creator | Ioannou, M. | en |
dc.creator | Gourgouliannis, K. I. | en |
dc.date.accessioned | 2015-11-23T10:43:38Z | |
dc.date.available | 2015-11-23T10:43:38Z | |
dc.date.issued | 2008 | |
dc.identifier.issn | 11053992 | |
dc.identifier.uri | http://hdl.handle.net/11615/31811 | |
dc.description.abstract | Anti-TNF-α agents have been used for the treatment of several autoimmune diseases, including rheumatoid arthritis. Recently observations indicate that treatment with anti-TNF-α agents is associated with increased risk of infectious diseases and especially tuberculosis. A case of a 78-year-old female with rheumatoid arthritis is described who developed miliary tuberculosis after treatment with infliximab. A brief review of the literature is presented. Copyright © Athens Medical Society. | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-45849102015&partnerID=40&md5=9eab9eb89ad224b40fd8e068ee9f8671 | |
dc.subject | Anti-TNF-α | en |
dc.subject | Infliximab | en |
dc.subject | Rheumatoid arthritis | en |
dc.subject | Tuberculosis | en |
dc.subject | tumor necrosis factor alpha antibody | en |
dc.subject | aged | en |
dc.subject | article | en |
dc.subject | case report | en |
dc.subject | clinical feature | en |
dc.subject | disease course | en |
dc.subject | female | en |
dc.subject | human | en |
dc.subject | infection risk | en |
dc.subject | miliary tuberculosis | en |
dc.title | Miliary tuberculosis in a patient with rheumatoid arthritis following treatment with anti-TNF-α | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |